Previous studies have shown that angiotensin I1 subtype 2 (AT,) receptors appear early during renal embryonic development. Factors involved in the regulation of AT, receptors during renal development, however, have not been investigated. The present study was designed 1 ) to characterize the ontogeny of renal AT, gene expression during the last half of gestation in fetal sheep and newborn lambs, 2) to compare changes in AT, and AT, gene expression during renal development, 3) to determine the influence of A11 in modulating renal AT, and AT, gene expression during fetal life, and 4) to characterize the role of cortisol in modulating renal AT, gene expression during the last trimester of gestation in fetal sheep. To perform these studies, we first isolated and cloned a polymerase chain reaction product that has 92 and 90% homology with the cDNA encoding the human and rat AT, receptors, respectively. Using this sheep AT, cDNA probe, we demonstrated that the sheep AT, gene was encoded in a single locus. In addition, we showed that renal AT, mRNA expression was high early during fetal life (60-90-d gestation) and decreased rapidly thereafter. In contrast, the expression of renal AT, receptor gene was low at 60-d gestation and increased during the last trimester of gestation. We found that a continuous i.v. infusion (1 mL/h) of A11 (9.5 nM/h) for 24 h, which raised plasma A11 levels from 84 t-9 pg/mL to 210 i-21 pg/mL, decreased the expression of both renal AT, and AT, genes in third trimester fetal sheep. On the other hand, we observed that cortisol, known to decrease AT, gene expression in the fetus, had no effect on AT, gene expression. In summary, this study demonstrates that AII, but not glucocorticoids, contributes to the regulation of renal AT, gene expression during development and that there is differential regulation of AT, and AT, receptors. (2), and the expression of renin, angiotensinogen, and angiotensinconverting enzyme genes appear to be developmentally regulated (3-6).
METHODS

Animals.
Studies were performed in fetal sheep and newborn lambs of Dorset and Suffolk mixed breeding, obtained from a local source. The gestational ages of the fetuses were based on the induced ovulation technique as previously described (17) .
Surgical preparatiorz and experimental protocols. Anesthesia and surgery of the ewe and fetus were performed as previously described (18) . Briefly, the ewe was fasted for 24 h before surgery and anesthetized using a mixture of halothane (I%), oxygen (33%), and nitrous oxide (66%).
In a first series of studies, we determined the ontogeny of the kidney AT, receptor during the fetal and neonatal periods in sheep. For these studies, pregnant ewes were anesthetized as described, and the uterus was exteriorized to gain access to the fetus. Samples of fetal kidney cortex were obtained at 60, 90, 120, and 140 d of gestation, term 145 d: four different fetuses were studied at 60-, 90-, and 120-d gestation and five fetuses were studied at 140-d gestation. Similar procedures were performed in anesthetized newborn lambs at 1 (n = 5) and 10 d (n = 6) of age. After being removed, the kidney cortex was snap frozen in liquid nitrogen and stored at -70°C.
In a second series of studies, we investigated the effects of cortisol on the renal expression of both AT, and AT, gene expression in 10 pairs of chronically instrumented twin fetal sheep at 130-d gestation. For these studies, surgery was performed under sterile conditions. Briefly, the uterus was opened over the fetal hindlimbs, and polyethylene catheters were placed into the fetal femoral arteries and veins of both twin fetuses as previously described (1 1). Additional catheters were secured in the peritoneal cavity of each twin. At the end of surgery, the fetal incisions were closed, and the fetus was returned to the uterus. Uterine and maternal abdominal muscles and maternal skin were closed in separate layers. All catheters were exteriorized through a s.c. tunnel and placed in a cloth pouch on the ewe's flank. Ampicillin sodium (Wyeth Laboratories, Philadelphia, Pa) was administered to the ewe intramuscularly before surgery (2 g ) and infused into the amniotic cavity after surgery (2 g). Pregnant ewes were returned to individual pens and allowed free access to food and water.
After a 72-h recovery period from surgery, one of each set of twins was given a continuous intraperitoneal infusion of cortisol (MW 484.52) for exactly 48 h at a rate of 3 mg/h (6.2 pmol/h) (1 mL/h). The other twin served as control. The infusion was carried out with a portable peristaltic infusion pump (Cormed, Inc., Middleport, NY) secured on the back of the ewe in a specially designed jacket that allowed the animals to move freely during the infusion. Fetal arterial blood pressure, heart rate, and amniotic pressure were monitored in each twin fetus for 30 min before and at the end of the 48-h intraperitoneal infusion of cortisol. Fetal arterial blood from each twin fetus was taken before and 48 h after starting the cortisol infusion for determination of arterial pH, Pco,, Po,, hematocrit, and plasma cortisol and A11 concentrations and PRA. At the end of the 48-h infusion period, the ewes were anesthetized as described, the uterine cavity was opened, and kidneys from both fetuses were removed, snap frozen in liquid nitrogen, and stored at -70°C.
In a third series of studies, we investigated the effects of A11 on the renal expression of AT,, AT,, and renin genes in nine pairs of chronically instrumented twin fetal sheep at 129 t 2 d of gestation (3.18 -t 0.1 1 kg). The surgical preparation was identical to what has been described for the second series of studies. Briefly, after a 72-h recovery from surgery, one of each set of twins was administered a continuous i.v. infusion of A11 (MW 1046) at a rate of 10 pg/h (9.5 nM/h) (3.17 + 0.11 ,ug-kg-'amin-') (1 mL/h) for exactly 24 h, as described for the second series of studies. Fetal arterial blood pressure, heart rate, and amniotic pressure were monitored in each twin fetus for 30 min before and at the end of the 24 h intraperitoneal infusion of AII. Fetal arterial blood from each twin fetus was taken before and 24 h after starting the A11 infusion for determination of arterial pH, Pco,, Po,, hematocrit, PRA, and plasma A11 concentrations. At the end of the 24-h infusion period, the kidneys were removed from both fetuses as described for the second series of studies, snap frozen in liquid nitrogen, and stored at -70°C.
All procedures were performed within the regulations of the Animal Welfare Act and the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and were approved by the University of Iowa Animal Care and Use Committee.
Analytical procedures. Arterial blood for pH, Pco,, and Po, was collected anaerobically in heparinized glass syringes, and measurements were immediately determined with appropriate pH, Pco,, and Po, electrodes at 39°C using an IL-1303 pH blood gas analyzer (Laboratory Instruments, Schaumburg IL). Hematocrit was determined in duplicate using a meter caliper. RIA, previously established in our laboratory, were used to measure plasma cortisol (19) and plasma A11 (20) concentrations and PRA (20, 21) .
Isolation of RNA. Total renal cortical cellular RNA was isolated using TRI-REAGENT (Molecular Research Center, Cincinnati OH). RNA was quantified spectrophotometrically by absorbance at 260 nm. RNA samples were stored as an ethanol precipitate at -70°C until further analysis.
Isolation, characterization, and sequencing of AT, partial cDNA from sheep kidney. A partial AT, cDNA clone was amplified by PCR from approximately 1 ng of cDNA after reverse transcription. Reverse transcription was performed with 1 pg of total RNA from sheep kidney using an avian myeloblastoma virus reverse transcriptase (BoehringerMannheim, Indianapolis IN).
PCR was performed using two specific primers prepared by a model 391 DNA synthesizer (Applied Biosystems, Foster 898 ROBILLARD ET AL.
City, CA) and derived from the first and sixth transmembrane domains of the rat AT, receptor (22, 23) . The sequence of primer 1 (forward) was 5'-GCA GAT AAG CTT TTG GAA GCA ATT CCT G-3', which was defined by bp 118-145 (22, 23) . The AT, primer 2 (reverse) encompassed bp 947-920 (22, 23) , and the sequence was 5'-AAG GAA TTC ACA CAG CTG TTG GTG AAT C-3'. The primer sequences differed from the corresponding rat AT, sequence (22, 23) by 1 nucleotide in primer 1 and 2 nucleotides in primer 2. Primer 1 had a T substituted for the A at site 128, and primer 2 had an A substituted for the G at site 943 and a C substituted for the A at site 939. These sequence alterations created a HindIII restriction site at the 5' end of the PCR product and an EcoRI restriction site at the 3' end. The conditions for PCR were 94°C for 1 min, 53°C for 1 rnin and 72°C for I rnin for 35 cycles; the first cycle was held at 94°C for 3 rnin instead of 1 min, and the final cycle had 5 rnin of primer extension time at 72°C.
The 830-bp PCR product was gel-purified (Qiaex; Qiagen, Chatsworth, CA) and cloned into the plasmid vector pT71 T318U (Ambion). Before ligation, both the PCR product and the plasmid vector were digested with HindIII and EcoRI. DNA sequencing was performed at the University of Iowa DNA Core Facility (Dave Moser, Director) on a model 373A automated DNA sequencer (Applied Biosystems) using vectorand sequence-specific primers, Taq DNA polymerase and fluorescent dye-labeled terminators. DNA and protein sequences were aligned using the program Bestfit from the Sequence Analysis Software Package of the Genetics Computer Group (24) .
Preparation of AT, RNA probe. The plasmid PAT, was treated with the restriction enzyme HindIII and then purified by phenol chloroform extraction and ethanol precipitation. The resultant linear plasmid was used to generate a labeled antisense RNA probe using T7 RNA polymerase (United States Biochem Corp., Cleveland, OH) and [ d -3 2~]~~~ (Amersham Corp, Arlington Heights, IL).
Preparation of AT, and renin RNA probes. A sheep AT, receptor partial cDNA sequence from nucleotide 114 to 783 was isolated as previously described (1 1). The plasmid PAT, was then treated with the restriction enzyme NdeI and purified by phenol extraction and ethanol precipitation. The resultant linear plasmid was used to generate a labeled antisense RNA probe (1 1).
A clone containing a 0.7-kb fragment of rat renin cDNA was also prepared from a full-length 1.43-kb rat renin cDNA (25) obtained from Dr. K. R. Lynch (University of Virginia, Charlottesville). This cDNA yields antisense RNA when transcribed from the T7 promoter after linearizing with EcoRI.
Preparation of 18s rRNA probe. An 18s rRNA probe was used to confirm equal loading and transfer of RNA. The 18s rRNA probe was prepared from an 18s cDNA clone corresponding to a 82-bp fragment of a highly conserved region of human 18s rRNA obtained from Ambion.
Northern blot hybridization. Aliquots of 5 pg of RNA were fractionated by formaldehyde-agarose gel electrophoresis (26) . After electrophoresis, RNA was transferred to a 0.45-pm Nytran filter. The filters were prehybridized for 1 h at 60°C in a solution of 50% deionized formamide, 5 X SSPE, 5 X Denhardt's reagent, 0.5% SDS, and 200 pg/mL denaturated sheared salmon sperm DNA. Hybridization of filters was carried out with fresh hybridization buffer solution containing 2 X lo6 counts-min-'.m~-' of the radiolabeled probe. The hybridization reaction was carried at 60°C for 12-18 h. Filters were then sequentially washed according to the manufacturer's specifications. This included three low stringency washes (1 X SSPE, 0.5% SDS) at 68°C and a high stringency wash (0.1 X SSPE, 0.5% SDS) at 65°C. Hybridization signals were detected and quantitated using an AMBIS 4000 Radioanalytic Imaging System (AMBIS, Inc., San Diego, CA) as previously described (1 1). Background counts above each lane were determined and subtracted from total counts generated in each region of interest to yield a net count value. In addition, the washed filters were exposed to Kodak XAR film at -70°C.
Southern blot hybridization. To test whether the sheep AT, gene was encoded in a single locus, genomic sheep DNA was isolated from sheep blood. Ten micrograms of DNA was digested with each of the following restriction enzymes BamHI, BglII, EcoRI, HindIII, and PstI according to the manufacturer (New England Biolabs, Inc., Berverly, MA). The digested DNA was separated on a 0.7% agarose gel and visualized on a UV transilluminator after staining with ethidium bromide. The DNA was transferred to a nylon membrane (Zeta Probe; Bio-Rad Laboratories, Hercules, CA) by capillary action and immobilized on the membrane by UV cross-linking (Stratalinker; Stratagene, LaJolla, CA). The partial cDNA probe of the sheep AT, gene was labeled with [ a -3 2~]~~~ by PCR using gene-specific primers (27) . Hybridization and detection were performed as suggested by the manufacturer (Bio-Rad).
Data analysis. For quantitation of mRNA abundance, all samples were analyzed together on a single Northern blot hybridization to control for day-to-day variations in hybridization efficiency. Northern blots were done in triplicate. Abundance of AT,, AT,, and renin mRNAs was expressed as total net radioactive counts, after subtracting background counts for each sample.
Comparisons among the different groups of animals were performed using one-way analysis of variance. When the analysis of variance indicated significant differences among groups, as calculated by the F statistic, the Duncan multiple comparison procedure was performed to determine significant differences between each group (28) . Paired and unpaired t tests were also used to compare means between two groups. Statistical significance is defined as y < 0.05, and the results are presented as mean ? SEM.
RESULTS
Isolation, characterization, and sequencing of AT2 receptor partial cDNA from sheep kidney. The sheep AT, partial cDNA sequence from nucleotide 142 to 921 and corresponding AT, cDNA sequences from other species are presented in Figure 1 . The deduced amino acid sequence from the sheep AT, partial cDNA and comparison between the sheep sequence and sequences from other species are presented in Figure 2 . The percent homology between the sheep AT, partial cDNA sequence and corresponding AT, cDNA sequences from other species is 92% with the human (29) and 90% with both the rat (22, 23) and the mouse (30) . The percent homology between the sheep AT, partial amino acid sequence and corresponding AT, amino acid sequences from other species is 96% with the human (29) and 95% with both the rat (22, 23) and the mouse (30) . To test whether the sheep AT, gene was encoded in a single locus, Southern blot analysis was performed on genomic sheep DNA using a partial cDNA probe from the sheep AT, gene (Fig. 3) . Several different restriction enzymes were tested and a single DNA fragment was detected suggesting the presence of a single AT, locus in the sheep.
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Renal AT, mRNA expression in fetal and newborn sheep. Renal AT, mRNA expression was higher early during fetal life (60-and 90-d fetal sheep) and decreased rapidly thereafter (Fig. 4A) ; the expression of the renal AT, gene decreased by 75% during the last trimester of gestation. After the first week of life, renal AT, gene expression was only 12% of the expression observed at 60-d gestation. Because 18s ribosomal mRNA levels (Fig. 4A, upperpanel) tended to be lower at 90-d gestation than at any other gestational age, one may suggest that renal AT, mRNA levels in 90-d fetuses may even be higher when factored for 18s ribosomal mRNA levels. In contrast to the high level of AT, mRNA expression early during fetal life, the expression of renal AT, receptor gene ( Effects of cortisol infusion on kidney AT, mRNA expression in third trimester fetal sheep. Previous studies by our group (11) have shown that cortisol produced a significant decrease in renal AT, mRNA abundance in fetal sheep during the last trimester of gestation. Using total RNA from kidneys used previously to investigate the role of cortisol on renal AT, mRNA expression (1 I), we characterized the effect of cortisol on renal AT, gene expression in 10 pairs of chronically instrumented fetal sheep studied at 130 + 1 d of gestation (term, 145 d in sheep). One of each set of twins received a continuous intraperitoneal infusion (1 mL/h) of cortisol for 48 h (3 mglh) (6.2 pmollh). Plasma cortisol concentrations increased from 32 t 7.1 nmol/L to 1126 % 231 n m o l k in cortisol treated fetuses ( p > 0.001) and changed only slightly in control fetuses from 22.7 % 3.6 nmol/L to 45.8 ? 8.2 nmolk. Cortisol infusion had no significant effect on fetal arterial pH, Po,, and Pco, and produced no significant changes in fetal plasma angiotensin I1 levels, as demonstrated previously (1 1).
A rise in fetal plasma cortisol levels had no significant effect on renal AT, mRNA levels (Fig. 5) . Hybridization of 18s rRNA probe showed no significant differences in renal 18s rRNA levels between control (1330 t 50 net counts) and cortisol-treated fetuses (1324 i 59 net counts).
Efects of A11 infusion on kidney AT,, AT,, and renin mRNA levels in third trimester fetal sheep. This series of studies was designed to characterize the effects of A11 in regulating the expression of kidney AT,, AT,, and renin mRNAs during the last trimester of gestation in fetal sheep. Nine pairs of chronically instrumented fetal sheep (129 f 2 d of gestation) were studied. One of each set of twins received a continuous i.v. infusion (1 rnL/h) of A11 (10 p g k or 9.5 nM/h) for 24 h. The effects of A11 infusion on fetal arterial blood values, mean arterial blood pressure, and heart rate in both control and ASS-treated fetuses are presented in Table 1 . No significant changes in arterial pH, Pco,, PO,, and hematocrit were observed in both control and AIS-treated fetuses. A11 infusion, however, produced a significant increase in plasma A11 concentration in AII-treated fetuses (from 84 +. 9 to 210 f 21 pg/mL), but had no effect in twin-match control fetuses. Significant decreases in PRA (from 4.68 i 1.49 to 2.05 f 0.67 ng A S .~L -' .~-' ) were also observed in AII-treated fetuses. A11 infusion increased arterial blood pressure from 54 f 2 to 76 2 5 mm Hg in AII-treated fetuses, but had no effects in control twin fetuses.
The effects of i.v. AS1 infusion on renal AT,, AT,, and renin mRNA levels are presented in Figures 6-8 . Northern blot hybridization demonstrated significant ( p < 0.05) decreases in both renal AT, (Fig. 6 ) and AT, (Fig. 7) mRNA levels in AII-treated fetuses when compared with twin-match control fetuses. Infusion of A11 produced significant decreases in renal AT, (-27.4 t 11.2%) and AT, (-31.1 1+-6.7%) mRNA levels. Twenty-four hours after starting the AS1 infusion, renal AT, and AT, mRNA levels expressed as 3 2~ were, respectively, 548 t 97 and 386 4 63 net counts in twin-match control fetuses and 375 t 57 and 253 f 38 net counts in AII-treated fetuses. A11 infusion produced also a significant decrease ( p < 0.01) in renal renin mRNA expression (Fig. 8) .
No significant differences were observed in renal 18s rRNA levels between AII-treated and twin-matched control fetuses, indicating similar RNA loading.
DISCUSSION
The present study suggests that the AT, gene is present in a single locus in the sheep, and demonstrates a high level of homology between the sheep AT, partial cDNA sequence and corresponding AT, cDNA sequences from other species (22, 23, 29, 30) . In addition, we have shown that the expression of AT, receptor mRNA in fetal sheep kidney is high during the second trimester of gestation and decreases rapidly thereafter. In contrast, renal AT, mRNA expression is low early during fetal life (60-d gestation), increases during the last trimester of gestation, and decreases after birth, confirming previous results
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A Net Counts (11) . This study also demonstrates that a rise in fetal plasma A11 levels produces significant decreases in the expression of 18s both renal AT, and AT, genes and in renal renin mRNA levels. Finally, we observed that cortisol, which is known to decrease renal AT, mRNA expression (1 I), had no significant effects on 60d 90d 120d140d I d 1Od renal AT, expression in near-term fetuses.
Previous studies using autoradiographic techniques have demonstrated that AT, receptors predominate in 15-17-wk gestation human fetal kidneys and are localized in both cortex and medulla (3 1, 32) . Similarly in the rat, AT, receptor binding sites appear first in immature renal structures (S-shaped glomeruli) (15), whereas AT, receptor sites are observed when kidney development reaches more advanced developmental stages (10, 15) . Using in situ hybridization, investigators have shown that the expression of both AT, and AT, mRNAs appear simultaneously in embryonic fetal mouse kidney (14-d gestation) (14) . However, it appears that, during fetal life in the rat, the pattern of distribution of AT, and AT, receptors differs (16) . Interestingly, the intensity of AT, mRNA's signal is greater than the AT, mRNA7s signal in several nephrogenic areas that undergo apoptosis after nephrogenesis (14) .
In agreement with previous fetal studies using autoradiographic techniques (10, 15, 31, 32) and in situ hybridization (14, 16, 33) , we found that both AT, and AT, receptors are developmentally regulated in the fetal sheep kidney. We have shown that the expression of AT, receptors is elevated early during fetal life (60-d gestation) and decreases rapidly during the third trimester of gestation, whereas AT, mRNA levels increase rapidly before birth, as previously described (11) . Adding to these previous results (1 I), we are now showing that the renal expression of AT, gene is low during the second trimester of gestation when renal AT, gene expression is elevated.
Factors regulating these changes is of intense current interest. It has been suggested that the differential regulation of AT, and AT, receptors during embryonic development is related to the different cell types in which these receptors are expressed (14) . For example, the cellular location of AT, expression in the embryonic kidney overlaps with cells undergoing apoptosis after nephrogenesis (14) . This suggests that programmed death of embryonic cells may contribute to the decreased expression in AT, receptors later during development. In addition, the modulatory effects of several growth factors may be also involved in regulating the expression of both AT, and AT, receptors during development (34, 35) . For example, plateletderived growth factor-BB reduces AT, and increases AT, binding sites in culture of rat aorta smooth muscle cells (35) . Other growth factors such as epidermal growth factor and endothelin-1 have a suppressive effect on AT, receptors (35) . 
The present results demonstrate that a rise in circulating levels of A11 produces a significant decrease in AT, receptor mRNA levels in fetal sheep kidney. These results differ from previous studies in adults (36, 37) AII. Similarly, sodium depletion, a condition associated with high plasma A11 levels, is not associated with a decrease in AT, receptor mRNA levels in adult rat kidneys (14) . Sodium depletion, however, produces a down-regulation of A11 receptor density (38) (39) (40) . On the other hand, other investigators have shown that A11 reduces AT,, receptor mRNA expression in cultured vascular smooth muscle cells (41) and mesangial cells (42) . Recent studies have also shown that agents that increase intracellular CAMP may induce a decrease in AT, receptor mRNA levels in glomerular mesangial cells (42) . Finally, it has been suggested that activation of protein kinases C and A can up-regulate both AT, receptor mRNA levels (43) and binding sites (44) . Further studies are needed to determine the role of these factors in the regulation of transduction and translation of AT, receptors during renal development. As for the AT, receptors, AT2 receptors located in the kidney are down-regulated by A11 during the last trimester of gestation in fetal sheep. This finding represents the first demonstration of a role of A11 in modulating AT, receptor expression in the developing kidney. Because we observed, however, that A11 produced an increase in fetal arterial blood pressure, one may suggest that blood pressure itself may participate in the down-regulation of AT, gene expression. In addition, because the present studies were performed in third trimester fetuses where the expression of AT2 receptor gene had already started to decrease, it remains unclear if A11 can decrease the expression of AT, receptors during the second trimester of gestation, when the expression of the AT, gene is elevated. Further studies are needed to determine the exact role of these receptors as well as the role of cGMP and phosphotyrosine phosphatase (45) in modulating the action, distribution, and decreases PRA in the fetus (20) . To our knowledge, it is the first demonstration that A11 participates in the regulation of renal renin gene expression during fetal life. The present results, however, do not allow us to determine whether this decline in renal renin gene expression during a rise in plasma A11 levels is secondary either to a direct action of A11 on the juxtaglomerular cells or to an increase in fetal renal perfusion pressure or both.
Another interesting observation is that glucocorticoids, which decrease renal AT, gene expression during the last trimester of gestation in fetal sheep ( l l ) , do not alter AT, mRNA levels. These results are somewhat different from previous studies in adult pancreatic acinar cells which demonstrate that glucocorticoids down-regulate AT, receptors (46) . It is not clear, however, if glucocorticoids would have an effect of AT, receptor gene expression at an earlier time during gestation when the expression of these receptors is higher. Additional studies are needed to clarify these issues.
In summary, renal AT, gene expression is high during the second trimester of gestation and decreases rapidly thereafter, whereas the expression of AT, receptor gene increases during the third trimester of gestation to decrease after birth. A11 produces similar decrease in the expression of both renal AT, and AT, genes during the third trimester of gestation in sheep. Glucocorticoids, which are known to decrease renal AT, gene expression in the fetus ( l l ) , do not significantly alter the expression of renal AT2 receptor gene during the last trimester of gestation.
